Table 5.
Treatment | SOD, U/mgprot | MDA, nmol/mgprot | LYZ, U/mL | C3, g/L | C4, g/L |
---|---|---|---|---|---|
Control | 387.06 ± 9.71a | 2.03 ± 0.11a | 1400.00 ± 43.26a | 0.49 ± 0.03ab | 0.45 ± 0.04a |
0.15% nucleotides | 478.59 ± 19.43b | 2.08 ± 0.17a | 1620.05 ± 60.41b | 0.53 ± 0.03ab | 0.45 ± 0.06a |
0.30% nucleotides | 434.76 ± 32.18ab | 1.87 ± 0.09b | 1671.43 ± 44.38b | 0.48 ± 0.09ab | 0.48 ± 0.01a |
0.60% nucleotides | 488.58 ± 27.91b | 1.72 ± 0.12c | 1557.14 ± 32.72ab | 0.60 ± 0.02a | 0.45 ± 0.05a |
1.20% nucleotides | 467.89 ± 12.37b | 1.73 ± 0.13c | 1541.27 ± 72.86ab | 0.44 ± 0.05b | 0.40 ± 0.01a |
a, b, c Data are means of triplicate, and presented as means ± SEM. Means in each column with a common superscript are not significantly different (P > 0.05).
SOD = super oxide dismutase; MDA = malondialdehyde; LYZ = lysozyme; C3 and C4 are complement proteins C3 and C4.